- The infectious disease burden in India is among the highest in the world, and hospital-acquired infections are of particular concern. These infections pose a great risk to the timely recovery of patients and are associated with high mortality rates. As a result, critical care medicines play a vital role in reducing morbidity and mortality. In addition, critical care patients have life-threatening conditions requiring healthcare professionals to often use a multi-pronged treatment approach that can affect the cost of daily therapy.
- To satisfy the unmet medical needs of seriously ill patients in intensive care units, criticure a division of” Suncure Lifescience Pvt. Ltd India launched, its Criticure division in 2016, with several high quality, affordable antifungal and antibacterial therapies.
